日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Talazoparib enhances the anti-angiogenic potential of quinacrine through the deregulation of P300 and GCN5 chromatin remodelers in patient-derived oral cancer stem cells

Talazoparib通过调控患者来源的口腔癌干细胞中P300和GCN5染色质重塑因子的表达,增强quinacrine的抗血管生成潜力。

Das, Chinmay; Paul, Subarno; Bhal, Subhasmita; Acharya, Sushree Subhadra; Dash, Somya Ranjan; Goswami, Aakash; Thakur, Aashi; Pathy, Pramod Chandra; Kundu, Chanakya Nath; Parija, Tithi

Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping.

talazoparib 和 olaparib 的联合应用通过 PARP-1 捕获增强了姜黄素介导的口腔癌细胞凋亡

Chatterjee Subhajit, Dhal Ajit Kumar, Paul Subarno, Sinha Saptarshi, Das Biswajit, Dash Somya Ranjan, Kundu Chanakya Nath